Top Markets
#1 Akedo Akedo +64.36%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +49.34%
#4 Cross Cross +45.41%
#5 Black Phoenix Black Phoenix +34.24%
#6 Velvet Velvet +30.05%
#7 OVERTAKE OVERTAKE +26.38%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +14.75%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +14.03%
#10 Palladium Network Palladium Network +12.84%
Coin of the day
Akedo Akedo
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
ZyVersa Therapeutics, Inc. ZyVersa Therapeutics, Inc.

ZyVersa Therapeutics, Inc.

ZVSA
Pozycja w akcjach #38794
ZyVersa Therapeutics, Inc. is a biopharmaceutical firm in its clinical... ZyVersa Therapeutics, Inc. is a biopharmaceutical firm in its clinical development phase, dedicated to advancing and commercializing therapies for renal (kidney) and inflammatory disorders. The company's pipeline prominently features VAR 200, a cholesterol efflux modulator aimed at addressing kidney diseases such as focal segmental glomerulosclerosis, Alport syndrome, and diabetic kidney disease. Furthermore, ZyVersa is advancing IC 100, a pioneering inflammasome ASC inhibitor positioned to tackle a wide array of inflammatory conditions. The company maintains its corporate headquarters in Weston, Florida.
Cena akcji
$0.099
Kapitalizacja rynkowa
$801.50K
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
-34.44%
Kraj
US
Handel ZyVersa Therapeutics, Inc. (ZVSA)

Kategoria

Healthcare
Wskaźnik P/B dla ZyVersa Therapeutics, Inc. (ZVSA)
Wskaźnik P/B na dzień 2026 TTM: 0
Według najnowszych raportów finansowych i ceny akcji ZyVersa Therapeutics, Inc., obecny wskaźnik P/B (TTM) wynosi 0. Na koniec 2026 wynosił 0.
Historia wskaźnika P/B dla ZyVersa Therapeutics, Inc. od 2026 do 2026
Wskaźnik P/B na koniec każdego roku
Rok Wskaźnik P/B Zmień
Za mało danych dla podanych dat.
Wskaźnik P/B dla podobnych firm lub konkurentów
Firma Wskaźnik P/B Różnica wskaźnika P/B Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.2613 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.3483 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.634 -
BE